31-Mar-2020 | Zion Market Research
As per Zion Market research, the global atrial fibrillation drugs market is projected to surpass US$ 16.5 billion by 2025 at a CAGR of almost 4.4 % in the forecast period. During years to come, the atrial fibrillation drugs market is projected to increase profitably.
Rising elderly population rates merged with elevated occurrence of valvular disease will power the growth of the market. Moreover, the elevated rate of diabetic people also adds to the development of the atrial fibrillation drugs market. The rising occurrence in developed and developing nations of CVD owing to an elevation in sedentary lifestyles and rise in habits of binge eating will boost the growth of the market.
Anticoagulants Segment Is Predicted To Have A Lion’s Share In The Global Market
Over the forecast period, the anticoagulants segment is predicted to develop by 4.4%. The rate of stroke in users suffering from atrial fibrillation was recognized to drop for a long period now. In addition to this, the increasing axiom by manufacturers on the development of oral anticoagulants has elevated the requirement for the goods. The above factors will thereby elevate the development of the global market. In addition to this, the appearance of more effectual oral anticoagulants in auricular fibrillation will eventually restore the employment of antiarrhythmic drugs. Hence, in the coming period, the global market is expected to boost in the near future.
China Expected To Witness Rapid Growth In The Global Market In The Years To Come
The US ruled the atrial fibrillation drugs market in North America with almost US$5.5 million in 2019. The US has grabbed the biggest share of the global market in the world due to increasing elderly population and the rising occurrence of valve diseases in the people. Moreover, the development of the atrial fibrillation market in the US will carry on with an ever rising number of drug makers, such as Bristol-Myers Squibb and Johnson and Johnson.
Over the years to come, China is anticipated to witness rapid growth in the atrial fibrillation drug market. The increasing acceptance of local private clinics and development of hospitals are all factors responsible for the growth of the global market. Moreover, the rising occurrence of heart diseases owing to a sudden transition in lifestyle and increasing binge eating patterns have boosted the development of the global market.
Browse the full “Atrial Fibrillation Drugs Market - By Type (Permanent, Paroxysmal, and Persistent), By Product (Anticoagulant Drugs and Antiarrhythmic Drugs), By Route of Administration (Oral and Injectable), By Application (Heart Rhythm Control and Heart Rate Control), By End Use (Hospitals, Cardiac Centers, and Ambulatory Surgical Centers) - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025.” Report at https://www.zionmarketresearch.com/report/atrial-fibrillation-drugs-market
The global atrial fibrillation drugs market is segmented as follows:
By Route Of Administration
By End Use
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651